Trial	Phase	Sponsor	Dist.
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	<1 mi
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	<1 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes	Phase 2	Hoffmann-La Roche	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes	Phase 1	Eli Lilly and Company	<1 mi
Maternal Abdominal Morphology Assessment	—	University of Texas at Austin	<1 mi
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy	Phase 2	Boehringer Ingelheim	<1 mi
Diabetes Prevention in Hispanic Adults Using Constant Glucose Monitors	N/A	University of Texas at Austin	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes	Phase 4	Ohio State University	<1 mi
Balance Control and Recovery in Diabetes Peripheral Neuropathy	N/A	Lisa Griffin	<1 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer	Phase 1/2	Aulos Bioscience, Inc.	<1 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers	N/A	LifeNet Health	<1 mi
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus	Phase 2	Ascletis Pharma (China) Co., Limited	<1 mi
Prevention of Progression of Prediabetes, Obesity and CV Risk	Phase 1	The University of Texas Health Science Center at San Antonio	<1 mi
Transformative Research in Diabetic Nephropathy	—	University of Pennsylvania	<1 mi
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist	Phase 2	AstraZeneca	<1 mi
SGLTi, Hepatic Glucose Production and Ketogenesis	Phase 1	The University of Texas Health Science Center at San Antonio	<1 mi
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia	Phase 1	The University of Texas Health Science Center at San Antonio	<1 mi
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)	Phase 1	Gilead Sciences	<1 mi
SGLT2i, Hepatic Glucose Production, and SNS	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants	Phase 4	The University of Texas Health Science Center at San Antonio	<1 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	<1 mi
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)	N/A	The University of Texas Health Science Center at San Antonio	<1 mi
SGLT2i, Pioglitazone, and Ketone Production in T2D	Phase 1	The University of Texas Health Science Center at San Antonio	<1 mi
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort	Phase 1	AstraZeneca	<1 mi
Dapagliflozin Plus Pioglitazone in T1DM	Phase 4	The University of Texas Health Science Center at San Antonio	<1 mi
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes	Phase 3	The University of Texas Health Science Center at San Antonio	<1 mi
Mirragen Diabetic Foot Ulcer Study	—	The University of Texas Health Science Center at San Antonio	<1 mi
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)	Phase 1	Merck Sharp & Dohme LLC	<1 mi
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes	Phase 4	Marzieh Salehi	<1 mi
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
Quantifying Hepatic Mitochondrial Fluxes in Humans	Phase 4	The University of Texas Health Science Center at San Antonio	<1 mi
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting	—	Bayer	<1 mi
Gastroparesis Registry 4	—	Johns Hopkins Bloomberg School of Public Health	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity	Phase 3	Eli Lilly and Company	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial	N/A	Sonavex, Inc.	<1 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	<1 mi
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	<1 mi
OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection	—	Optain Health	<1 mi
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's	N/A	Compedica Inc	<1 mi
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)	—	M.D. Anderson Cancer Center	<1 mi
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents	N/A	Baylor College of Medicine	<1 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Abliva AB	<1 mi
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing	Phase 4	BioXTek	<1 mi
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial	N/A	Baylor College of Medicine	<1 mi
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases	Phase 3	Khondrion BV	<1 mi
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents	N/A	Baylor College of Medicine	<1 mi
RESET System Pivotal Trial (Rev F)	N/A	Morphic Medical Inc.	<1 mi
Immune Function and the Progression to T1D	—	University of Florida	<1 mi
Rare and Atypical Diabetes Network	—	University of South Florida	<1 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations	N/A	Capsicure, LLC	<1 mi
Arginine Metabolism in Youth With Type 2 Diabetes	N/A	Baylor College of Medicine	<1 mi
Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis	—	Lilli Health	<1 mi
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes	N/A	The University of Texas Health Science Center, Houston	<1 mi
Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes	N/A	Baylor College of Medicine	<1 mi
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer	Phase 3	Energenesis Biomedical Co., Ltd.	<1 mi
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes	N/A	Baylor College of Medicine	<1 mi
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth	—	George Washington University	<1 mi
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility	N/A	Hamad Medical Corporation	<1 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL	Phase 4	HealthTech Wound Care	<1 mi
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study	Early 1	M.D. Anderson Cancer Center	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions	N/A	University of Texas Southwestern Medical Center	<1 mi
Non-Invasive Testing to Evaluate Wound Healing in Diabetes	—	University of Texas Southwestern Medical Center	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	<1 mi
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes	Phase 3	Vertex Pharmaceuticals Incorporated	<1 mi
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	<1 mi
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs	N/A	New Horizon Medical Solutions	<1 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	<1 mi
Polypill for Prevention of Cardiomyopathy	Phase 1/2	University of Texas Southwestern Medical Center	<1 mi
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study	N/A	University of Texas Southwestern Medical Center	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes	N/A	University of Texas Southwestern Medical Center	<1 mi
Tailored Exercise Training Study Among Adults With HFpEF	Phase 2/3	University of Texas Southwestern Medical Center	<1 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	13 mi
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	13 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.	Phase 4	Royal Biologics	13 mi
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	19 mi
A Real-World Registry of Chronic Wounds and Ulcers	—	U.S. Wound Registry	28 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	31 mi
ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community	N/A	Sam Houston State University	39 mi
The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults	N/A	Dartmouth-Hitchcock Medical Center	47 mi
Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)	N/A	The University of Texas Medical Branch, Galveston	47 mi
Healthy Communities Through CHW Initiatives	N/A	The University of Texas Medical Branch, Galveston	47 mi
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems	N/A	RxFunction Inc.	47 mi
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment	N/A	The University of Texas Medical Branch, Galveston	47 mi
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults	N/A	Dartmouth-Hitchcock Medical Center	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.